Is Buying Qualcomm Stock a Smart Health Care Play?


Normally when we think of investing in health care, medical device makers, pharmaceutical companies, and health insurers come to mind. However, buying Qualcomm stock could actually be a smart health care play as well. Here's why.

Mobile medical
What does a mobile communications giant have in common with health care? More than you might think -- especially in the growing area of telemedicine.

Telemedicine basically involves using medical information gathered at one location and sending this information electronically to another location to improve a patient's health. The opportunity for this technology to make a difference in improving health care is tremendous. Deloitte projects that $400 billion each year could be saved by using technology to address medical needs at home.

It's in the area of telemedicine that Qualcomm's technology shines. The company formed a business unit called Qualcomm Life in late 2011. Qualcomm Life focuses on remote health management using its 2net cloud platform. 2net enables integration of medical devices at a patient's home with a database hosted in the cloud. Other applications can access this data to provide a wide range of services to improve health care.

Plenty of companies have jumped on board Qualcomm's platform for telemedicine. At least 22 medical applications now use 2net. Others are on the way.

For example, WebMD is working to create a new offering to provide customers with "seamlessly connected personal wireless health data." WebMD plans to use 2net to integrate data captured via medical devices into its network of mobile applications and websites.

Over half of all consumers who take action to improve their health do so with information obtained through WebMD. The WebMD deal underscored Qualcomm's leadership role in the telecommunications arena.

Qualcomm isn't leaving all the fun to other companies, though. In May, Qualcomm Life acquired HealthyCircles, which provides a software-as-a-service tool that supports transition of patients from hospital to home. Such transitions will continue to rise in importance as Accountable Care Organizations, or ACOs, gain prominence.

Looking ahead
The downside to buying Qualcomm stock as a health care investment for now is that we really don't know how much revenue the company is making from the sector. Qualcomm made more than $19 billion in fiscal 2012, but the company doesn't break out the amount of revenue attributable to specific industries.Whatever that amount is, though, expect it to grow considerably.

InMedica, a research firm specializing in medical electronics, thinks that the telemedicine market could expand nearly 500% within the next four years. For its part, Qualcomm says that its future success depends in part on focusing on digital health opportunities.

There are many other great investment choices that are pure plays in the health care arena. However, for investors looking to capitalize on the "next big thing" for health care, my view is to take a hard look at buying Qualcomm stock. I suspect doing so will be a very smart move.

The mobile revolution is still in its infancy, but with so many different companies it can be daunting to know how to profit in the space. Fortunately, The Motley Fool has released a free report on mobile named "The Next Trillion-Dollar Revolution" that tells you how. The report describes why this seismic shift will dwarf any other technology revolution seen before it and also names the company at the forefront of the trend. You can access this report today by clicking here -- it's free.

The article Is Buying Qualcomm Stock a Smart Health Care Play? originally appeared on

Fool contributor Keith Speights has no position in any stocks mentioned. The Motley Fool owns shares of Qualcomm. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Originally published